Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

Inclusion Criteria:

Provision of signed and dated informed consent form
Male ≥ 18 years of age

Patients meeting clinical need for Illuccix PET scan:

Patients with suspected metastasis who are candidates for initial definitive therapy
Patients with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level
Patient is physically able to lay flat for the PET-CT procedure

Exclusion Criteria:

1. Assessment by the Investigator as unable or unwilling to comply with the requirements of the protocol.